Solid Biosciences, Inc. (SLDB)
6.88
+0.72
(+11.69%)
USD |
NASDAQ |
Jan 22, 14:17
Solid Biosciences Research and Development Expense (Annual): 96.43M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Revolution Medicines, Inc. | 584.60M |
| Perspective Therapeutics, Inc. | 39.33M |
| Electromed, Inc. | 0.996M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 2.385M |